Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms

Brett A. Chromy, Maher Elsheikh, Tova L. Christensen, Doug Livingston, Kyle Petersen, Jane P. Bearinger, Paul D. Hoeprich

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'Repurposing screens identify rifamycins as potential broad-spectrum therapy for multidrug-resistant Acinetobacter baumannii and select agent microorganisms'. Together they form a unique fingerprint.

Medicine & Life Sciences